About Chrysa Mineo
Chrysa Mineo is a director at Vetmab Biosciences.
Chrysa Mineo reports to the SEC as a director or officer of 2 public companies: Cidara Therapeutics (CDTX) and Receptos (RCPT).
Chrysa Mineo first appears on SEC filings in 2013.
Experience
This experience comes from Chrysa Mineo's profile and from SEC filings. For roles taken from filings, the years are when the filings name Chrysa Mineo in the role, so the role may have started earlier or lasted longer.
Vetmab Biosciences, Inc. Current
Member, Board of Directors
2025 – Present · San Diego, CA
Develops antibody treatments for veterinarians caring for dogs and cats.
SO
Scripps Institution of Oceanography Current
Member, Director's Council
2019 – Present
CI
Cidara Therapeutics, Inc. Current
Member, Board of Directors
2018 – Present · Public company (CDTX)
AB
Alume Biosciences Current
Co-Founder
2017 – Present
SM
San Diego Natural History Museum
Member, Board of Directors
2019 – 2025
SS
San Diego French American School
Member, Board Of Trustees
2017 – 2020
EC
Evonexus Committee
Member
2015 – 2018
RI
Receptos, Inc.
SVP, Corporate Development
Senior Vice President, Corporate Development (2009 – 2015)
2009 – 2015 · Public company (RCPT)
NB
Neurocrine Biosciences
Sr. Director, Business Development
1997 – 2009
BH
Baxter Healthcare
Business Development/Marketing
1995 – 1997
DI
DNAX Research Institute
Research Associate
1990 – 1992
AM
Amgen
Research Associate
1987 – 1990
Key Colleagues at Startups
The people Chrysa Mineo works with at each company, as listed on that company's latest Form D.
Vetmab Biosciences, Inc. · Form D, Sep 29, 2026
Denise Bevers
Co-founder, President & CEO, Board Member
Richard Chin
Co-founder, Chair of the Board
Hangjun Zhan
Director
NA
Neeraj Agrawal
Director